Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 4
1990 2
1991 2
1992 2
1993 4
1994 13
1995 7
1996 5
1997 5
1998 4
1999 5
2000 6
2001 5
2002 7
2003 14
2004 8
2005 7
2006 6
2007 8
2008 10
2009 9
2010 13
2011 15
2012 18
2013 15
2014 12
2015 15
2016 17
2017 7
2018 6
2019 18
2020 12
2021 13
2022 8
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Results by year

Filters applied: . Clear all
Page 1
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, Burtness B, Ghi MG, Cohen EEW, Grau C, Wolf G, Hitt R, Corvò R, Budach V, Kumar S, Laskar SG, Mazeron JJ, Zhong LP, Dobrowsky W, Ghadjar P, Fallai C, Zakotnik B, Sharma A, Bensadoun RJ, Ruo Redda MG, Racadot S, Fountzilas G, Brizel D, Rovea P, Argiris A, Nagy ZT, Lee JW, Fortpied C, Harris J, Bourhis J, Aupérin A, Blanchard P, Pignon JP; MACH-NC Collaborative Group. Lacas B, et al. Radiother Oncol. 2021 Mar;156:281-293. doi: 10.1016/j.radonc.2021.01.013. Epub 2021 Jan 27. Radiother Oncol. 2021. PMID: 33515668 Free PMC article.
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall E, van As N; PACE Trial Investigators. Tree AC, et al. Lancet Oncol. 2022 Oct;23(10):1308-1320. doi: 10.1016/S1470-2045(22)00517-4. Epub 2022 Sep 13. Lancet Oncol. 2022. PMID: 36113498 Free article. Clinical Trial.
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Petit C, Lacas B, Pignon JP, Le QT, Grégoire V, Grau C, Hackshaw A, Zackrisson B, Parmar MKB, Lee JW, Ghi MG, Sanguineti G, Temam S, Cheugoua-Zanetsie M, O'Sullivan B, Posner MR, Vokes EE, Cruz Hernandez JJ, Szutkowski Z, Lartigau E, Budach V, Suwiński R, Poulsen M, Kumar S, Ghosh Laskar S, Mazeron JJ, Jeremic B, Simes J, Zhong LP, Overgaard J, Fortpied C, Torres-Saavedra P, Bourhis J, Aupérin A, Blanchard P; MACH-NC and MARCH Collaborative Groups. Petit C, et al. Among authors: lartigau e. Lancet Oncol. 2021 May;22(5):727-736. doi: 10.1016/S1470-2045(21)00076-0. Epub 2021 Apr 13. Lancet Oncol. 2021. PMID: 33862002
Are hybrid conferences the new standard?
Baumann M, Bacchus C, Aznar MC, Coppes RP, Deutsch E, Georg D, Haustermans K, Hoskin P, Krause M, Lartigau EF, Lee AWM, Löck S, Offersen BV, Overgaard J, Thwaites DI, van der Kogel AJ, van der Heide UA, Valentini V. Baumann M, et al. Among authors: lartigau ef. Radiother Oncol. 2023 Jul;184:109695. doi: 10.1016/j.radonc.2023.109695. Epub 2023 May 6. Radiother Oncol. 2023. PMID: 37150445 No abstract available.
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Brand DH, Tree AC, Ostler P, van der Voet H, Loblaw A, Chu W, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Henderson D, Brown S, Cruickshank C, Burnett S, Duffton A, Griffin C, Hinder V, Morrison K, Naismith O, Hall E, van As N; PACE Trial Investigators. Brand DH, et al. Lancet Oncol. 2019 Nov;20(11):1531-1543. doi: 10.1016/S1470-2045(19)30569-8. Epub 2019 Sep 17. Lancet Oncol. 2019. PMID: 31540791 Free PMC article. Clinical Trial.
[Oncologic radiotherapy].
Thariat J, Giraud P, Mazeron JJ, Lartigau E. Thariat J, et al. Among authors: lartigau e. Bull Cancer. 2010 Jul;97(7):737-8. doi: 10.1684/bdc.2010.1158. Bull Cancer. 2010. PMID: 20675269 Free article. French. No abstract available.
Stereotactic body radiotherapy.
Lartigau E. Lartigau E. BMJ. 2011 Aug 3;343:d4286. doi: 10.1136/bmj.d4286. BMJ. 2011. PMID: 21816739 No abstract available.
[Safety in brachytherapy].
Marcié S, Marinello G, Peiffert D, Lartigau É. Marcié S, et al. Among authors: lartigau e. Cancer Radiother. 2013 Apr;17(2):166-9. doi: 10.1016/j.canrad.2013.01.004. Epub 2013 Mar 1. Cancer Radiother. 2013. PMID: 23465784 Review. French.
Radiation oncology in the new virtual and digital era.
Aznar MC, Bacchus C, Coppes RP, Deutsch E, Georg D, Haustermans K, Hoskin P, Krause M, Lartigau EF, Löck S, Offersen B, Overgaard J, Thwaites DI, van der Kogel AJ, van der Heide UA, Valentini V, Baumann M. Aznar MC, et al. Among authors: lartigau ef. Radiother Oncol. 2021 Jan;154:A1-A4. doi: 10.1016/j.radonc.2020.12.031. Epub 2020 Dec 30. Radiother Oncol. 2021. PMID: 33387585 Free PMC article. No abstract available.
288 results